Username Password
S&P 500: 1,317.45 Change: +0.03%
mkittels
P&P Score: 99.59 | Points: 138.74 | Accuracy: 40.70 | Average Pick Score: 2.95   Annual Return: N/A  
Open
 
Closed
 
All
 
Commentary
BUY: BIOCRYST PHARMACEUTICALS INC. (BCRX) Rating: 3
Start Price: $2.61
Points: +20.03
Created: 11/23/2011
biotech, flu treatment and promising gout drug that does not harm kidneys

1 Comment(s):

Author mkittels     Date 2012-01-28 16:50:44
Taking profit. This company, with a flu treatment that is superior to the protocol, still has great potential I think. So I will likely buy it again in the future.
Want to comment on this post? Sign up now. It's FREE!
Already registered? Log In.

register
Sponsored Links